Abstract
Stem cell banks with a number of qualified stem cell lines deposited are essential to facilitate biomedical applications of stem cells. Iran, which is active in the field of stem cell research and therapy and to meet the needs, has established stem cell banks. In this chapter, Iranian stem cell banks, which are divided into research and therapeutic banks, will be presented. We introduce here the Royan Stem Cell Bank (RSCB), Iran’s only research stem cell bank, and describe the process used for quality control and documentation. Finally, we discuss the future landscape of stem cell banking in Iran and the required steps for establishing good manufacturing practice (GMP) banks in order to improve the current state in Iranian stem cell therapy centers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Miremadi T, Salekdeh GH, Aghdami N, Gharanfoli M, Vasei M, Kouhkan A, Baharvand H. Stem cell research and therapy in the Islamic republic of Iran: pioneering in the Islamic world. Stem Cells Dev. 2013;22:51–7.
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–7.
Isasi RM, Knoppers BM. Governing stem cell banks and registries: emerging issues. Stem Cell Res. 2009;3:96–105.
Stacey GN, Masters JR. Cryopreservation and banking of mammalian cell lines. Nat Protoc. 2008;3:1981–9.
Baharvand H, Ashtiani SK, Valojerdi MR, Shahverdi A, Taee A, Sabour D. Establishment and in vitro differentiation of a new embryonic stem cell line from human blastocyst. Differentiation. 2004;72:224–9.
Totonchi M, Taei A, Seifinejad A, Tabebordbar M, Rassouli H, Farrokhi A, et al. Feeder- and serum-free establishment and expansion of human induced pluripotent stem cells. Int J Dev Biol. 2010;54:877–86.
Hassani SN, Totonchi M, Farrokhi A, Taei A, Larijani MR, Gourabi H, Baharvand H. Simultaneous suppression of TGF-beta and ERK signaling contributes to the highly efficient and reproducible generation of mouse embryonic stem cells from previously considered refractory and non-permissive strains. Stem Cell Rev. 2012;8:472–81.
Hassani SN, Totonchi M, Sharifi-Zarchi A, Mollamohammadi S, Pakzad M, et al. Inhibition of TGFbeta signaling promotes ground state pluripotency. Stem Cell Rev. 2014;10(1):16–30.
Baharvand H, Ashtiani SK, Taee A, Massumi M, Valojerdi MR, Yazdi P, et al. Generation of new human embryonic stem cell lines with diploid and triploid karyotypes. Dev Growth Differ. 2006;48:117–28.
Taei A, Gourabi H, Seifinejad A, Totonchi M, Shahbazi E, Valojerdi MR, et al. Derivation of new human embryonic stem cell lines from preimplantation genetic screening and diagnosis-analyzed embryos. In Vitro Cell Dev Biol Anim. 2010;46:395–402.
Taei A, Hassani SN, Eftekhari-Yazdi P, Rezazadeh Valojerdi M, Nokhbatolfoghahai M, Masoudi NS, et al. Enhanced generation of human embryonic stem cells from single blastomeres of fair and poor-quality cleavage embryos via inhibition of glycogen synthase kinase beta and Rho-associated kinase signaling. Hum Reprod. 2013;28:2661–71.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–72.
Ghodsizadeh A, Taei A, Totonchi M, Seifinejad A, Gourabi H, Pournasr B, et al. Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev. 2010;6:622–32.
Seifinejad A, Taei A, Totonchi M, Vazirinasab H, Hassani SN, Aghdami N, et al. Generation of human induced pluripotent stem cells from a Bombay individual: moving towards “universal-donor” red blood cells. Biochem Biophys Res Commun. 2010;391:329–34.
Totonchi M, Taei A, Seifinejad A, Tabebordbar M, Rassouli H, Farrokhi A, et al. Feeder- and serum-free establishment and expansion of human induced pluripotent stem cells. Int J Dev Biol. 2010;54:877–86.
Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint MT, et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol. 1988;70:177–82.
Bacigalupo A, Hows J, Gordon-Smith EC, Gluckman E, Van Lint MT, Congiu M, et al. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT working party. Bone Marrow Transplant. 1988;3:531–5.
Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174–8.
Butler MG, Menitove E. Umbilical cord blood banking: an update. J Assist Reprod Genet. 2011;28:669–76.
Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012;379:713–20.
Dunnett SB, Rosser AE. Cell transplantation for Huntington’s disease should we continue? Brain Res Bull. 2007;72:132–47.
Lunn JS, Sakowski SA, Hur J, Feldman EL. Stem cell technology for neurodegenerative diseases. Ann Neurol. 2011;70:353–61.
Mothe AJ, Tator CH. Advances in stem cell therapy for spinal cord injury. J Clin Invest. 2012;122:3824–34.
Baghbaderani BA, Mukhida K, Sen A, Kallos MS, Hong M, Mendez I, Behie LA. Bioreactor expansion of human neural precursor cells in serum-free media retains neurogenic potential. Biotechnol Bioeng. 2010;105:823–33.
Moroni L, Fornasari PM. Human mesenchymal stem cells: a bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues. J Cell Physiol. 2013;228:680–7.
Smith AJ, Smith JG, Shelton RM, Cooper PR. Harnessing the natural regenerative potential of the dental pulp. Dent Clin North Am. 2012;56:589–601.
Konno M, Hamabe A, Hasegawa S, Ogawa H, Fukusumi T, Nishikawa S, et al. Adipose-derived mesenchymal stem cells and regenerative medicine. Dev Growth Differ. 2013;55:309–18.
Thirumala S, Goebel WS, Woods EJ. Manufacturing and banking of mesenchymal stem cells. Expert Opin Biol Ther. 2013;13:673–91.
Acknowledgment
This study was funded by a grant provided from Royan Institute and Iranian Council of Stem Cell Research and Technology.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
6 Appendix 1
6 Appendix 1
1.1 6.1 RSCB Software
Because of having deposited the multiple cell lines, their variability and different passage numbers, with the help of Royan Institute bioinformatics experts RSCB designed and set up software for organizing this information. Right now this software is being used regularly for storage, retrieval, and sorting reports of the available cell lines in RSCB.
The system required for RSCB software installation:
-
Windows 8, Windows 7, Windows 2000, Windows XP, Windows Vista, or other NT windows.
-
Microsoft Office Excel and Microsoft Office Word 2003 or upper.
-
Microsoft SQL Server 2000 or upper.
-
Microsoft .NET Framework 3.5 or upper.
1.1.1 6.1.1 Software Installation
If the system is compatible with the software, a page will automatically appear (Fig. 12.5a) prompting the user to install the software in the desired location of computer’s hardware. After installation and for its first time application, user form requiring personal information must be filled (as an admin, administrator or public user) and sent to the bioinformatics group for receiving an activation code (each user and system will receive the code only once) (Fig. 12.5b, c).
1.1.2 6.1.2 Application of the Software
After software activation, there are three types of connection for different servers (which can be defined) for using the program (Fig. 12.6a):
-
Internet connection (wherever the Internet is accessible, connection to the software is possible).
-
Local connection (which is applicable in the interior network of the defined server).
-
This computer, the computer which is applicable only for the main server.
The next opened page requires user name and password received from the administrator (Fig. 12.6b).
In this step, the user can enter the data center (Fig. 12.6c) or, if the user is a program administrator, he or she can add other people as users (Fig. 12.6d).
After choosing data center, for admin users this page has searching, adding and editing tabs, which will be described later. For public users, only the search tab is active, whereas the management tab is only active for the manager.
1.1.3 6.1.3 Search in RSCB Software
Each user can access the RSCB information according to their needs. For example, choosing the “Availability” option will prompt the user to entering cell line specific code. As a result, the user will be informed about the number of available vials/straws for the particular cell line of interest (straw number is only for samples which have been frozen using vitrification method) (Fig. 12.7a). Furthermore, it is possible to define the minimum number of cryovials and straws. If their available number reduced drastically, the user would be informed by software alarm (Fig. 12.7b).
For more information about the status of a cell line (e.g., establishment date, passage number, and cryopreservation method), the user should choose the “Whole” option. The user can narrow the search results by choosing different options cited on the “Search” page (Fig. 12.8a). On the result page, the user may narrow the results by choosing column option (Fig. 12.8b, c) and save them in an Excel format by choosing the print option (Fig. 12.8d).
By choosing catalog options, the user may access the cell line certificate file, which is in PDF format (the administrator can upload new cell lines certificates or update the previous ones). By choosing the “edit” option the user can view the cell line information and/or edit it. Apart from these methods, the user can use advanced search options (Fig. 12.9).
1.1.4 6.1.4 Adding Cryopreserved Cell Lines Information
To add new information on crypopreservation of cells, the user should first choose the organism type, then choose the applied cryopreservation method, and finally fill in the cryopreservation form and save the data (Fig. 12.10).
1.1.5 6.1.5 Editing Saved Information
The user can edit the data independently by entering each cell line ID and choosing its cryopreservation method (Fig. 12.11).
1.1.6 6.1.6 Overall Management of the Program
The software is managed by an administrator, who has been defined and, among other, has also the following “privileges” (Fig. 12.12):
-
1.
Witnessing events: To view users’ activity with exact date and time.
-
2.
Observing user names: To check the activity or lack of activity of each user.
-
3.
Entering data: To enter text data.
-
4.
Elimination of data: To delete part of a data or all of it.
-
5.
Editing data: To edit saved data.
-
6.
Recovery: To take a backup from data or recover them.
-
7.
Data center configuration: To change data center names and send messages to users.
-
8.
Blocking data center: To block the data center whenever alterations have to be done in order to prevent unpredictable errors.
-
9.
Changing password.
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Haghparast, N. et al. (2014). Stem Cell Banking in Iran. In: Ilic, D. (eds) Stem Cell Banking. Stem Cell Biology and Regenerative Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0585-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0585-0_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0584-3
Online ISBN: 978-1-4939-0585-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)